DIN 02394782 — APO-OXYCODONE CR 60 MG
APO-OXYCODONE CR is a tablet (extended-release) of Oxycodone marketed by APOTEX INC. The full Oxycodone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02394782
- Brand name
- APO-OXYCODONE CR
- Active ingredient
- Oxycodone
- Strength
- 60 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Opioid analgesic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Oxycodone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02366754 | APO-OXYCODONE CR | 10 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02394766 | APO-OXYCODONE CR | 15 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02366762 | APO-OXYCODONE CR | 20.0 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02394774 | APO-OXYCODONE CR | 30 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02306530 | APO-OXYCODONE CR | 40 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02366746 | APO-OXYCODONE CR | 5.0 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02366789 | APO-OXYCODONE CR | 80.0 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02240131 | OXY.IR | 10 MG | TABLET | PURDUE PHARMA | MARKETED |
| 02240132 | OXY.IR | 20 MG | TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | MARKETED |
| 02231934 | OXY.IR | 5 MG | TABLET | PURDUE PHARMA | MARKETED |
| 02372525 | OXYNEO | 10 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02372533 | OXYNEO | 15 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02372797 | OXYNEO | 20 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02372541 | OXYNEO | 30 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02372568 | OXYNEO | 40 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02372576 | OXYNEO | 60 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02372584 | OXYNEO | 80 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02319985 | PMS-OXYCODONE | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02319993 | PMS-OXYCODONE | 20 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02319977 | PMS-OXYCODONE | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02309882 | PMS-OXYCODONE CR | 10 MG | TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02309890 | PMS-OXYCODONE CR | 20 MG | TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02309904 | PMS-OXYCODONE CR | 40 MG | TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 02309912 | PMS-OXYCODONE CR | 80 MG | TABLET (EXTENDED-RELEASE) | PHARMASCIENCE INC | MARKETED |
| 00443948 | SUPEUDOL 10 | 10 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02262983 | SUPEUDOL 20 | 20 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 00789739 | SUPEUDOL 5 | 5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |